, Protagonist Therapeutics Inc (NASDAQ:PTGX)’s traded shares were 0.85 million, with the beta value of the company hitting 2.11. , the stock’s price was $34.51, reflecting an intraday gain of 8.25% or $2.63. The 52-week high for the PTGX share is $35.96, that puts it down -4.2 from that peak though still a striking 60.24% gain since the share price plummeted to a 52-week low of $13.72. The company’s market capitalization is $2.02B, and the average trade volume was 601.45K shares over the past three months.
Protagonist Therapeutics Inc (NASDAQ:PTGX) trade information
Protagonist Therapeutics Inc (PTGX) registered a 8.25% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 8.25% in intraday trading to $34.51, hitting a weekly high. The stock’s 5-day price performance is 6.97%, and it has moved by 23.82% in 30 days. Based on these gigs, the overall price performance for the year is 22.86%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Protagonist Therapeutics Inc (PTGX) estimates and forecasts
Statistics show that Protagonist Therapeutics Inc has outperformed its competitors in share price, compared to the industry in which it operates. Protagonist Therapeutics Inc (PTGX) shares have gone up 47.23% during the last six months, with a year-to-date growth rate more than the industry average at 264.03% against 15.50.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 4.38%. While earnings are projected to return 220.33% in 2024.
PTGX Dividends
Protagonist Therapeutics Inc is due to release its next quarterly earnings in July. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
